AMRX

NASDAQ · Pharmaceuticals

Amneal Pharmaceuticals Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$18.71

+0.43 (+2.35%)

AMRX News1 articles

Ipsen Drops 7% as Amneal Launches Somatuline Generic

Ipsen shares dropped 7.3% after Amneal launched a generic version of its top-selling drug Somatuline Depot, erasing €955 million in market value.